Checkpoint Therapeutics, Inc. CKPT 深 滬
已收盤 05-30 16:00:00 美东时间
4.26
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 4.26
- 總市值 3.71亿
- 52周最高 4.50
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.80
- 委 比 0.00%
- 總股本 8702.00万
- 歷史最高 105.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.30
- 每 手 1
- 風險率 0.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
Fortress Biotech's subsidiary, Checkpoint Therapeutics, has been acquired by Sun Pharma for $4.10 per share in cash, plus a contingent value right (CVR) up to $0.70 per share. Fortress will receive ~$28 million immediately, a 2.5% royalty on UNLOXCYT™ sales, and up to $4.8 million via CVR if certain conditions are met. UNLOXCYT™, the first FDA-approved PD-L1 blocker for advanced cutaneous squamous cell carcinoma, will be commercialized globally v...
05-30 14:47
Checkpoint Therapeutics Reports Q1 2025 Financials and Updates
Checkpoint Therapeutics ( ($CKPT) ) has released its Q1 earnings. Here is a bre...
05-24 11:50
Checkpoint Therapeutics Q1 EPS $(0.19) Misses $(0.17) Estimate
Checkpoint Therapeutics (NASDAQ:CKPT) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.17) by 11.76 percent. This is a 42.42 percent increase over losses of $(0.33) per
05-14 04:42
美股大行评级 | 潜在涨幅778.38%！HC Wainwright & Co.上调BioLine Rx目标价至26美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1113752959213998081.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持BioLine Rx(BLRX)"买入"评级，目标价从9美元升至26美元</p> <p>• 德银：上调固特异轮胎橡胶(GT)评级至"买入"，目标价13美元</p> <p
04-01 09:48
Checkpoint Therapeutics GAAP EPS of -$1.42
Checkpoint Therapeutics press release (NASDAQ:CKPT): FY GAAP EPS of -$1.42. As of December 31, 2024, Checkpoint’s cash and cash equivalents totaled $6.6 million, compared to $4.9 million at December 3...
03-28 20:32
Fortress Biotech FY 2024 Earnings Preview
Fortress Biotech (NASDAQ:FBIO) is scheduled to announce FY earnings results on Wednesday, March 26th, after market close. The consensus EPS Estimate is -$3.28 (+61.3% Y/Y) and the consensus Revenue Es...
03-26 05:35
美股大行评级 | 美银证券：维持雅培"买入"评级，目标价从133美元升至150美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1106501041932570625.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Roth MKM：维持CervoMed Inc.(CRVO)"买入"评级，目标价从7美元升至15美元</p> <p>• Oppenheimer：维持Trevi Therapeutics(TRVI)"跑赢大市"评级，目标价从
03-12 11:01
美股牛股 | 美国房地产Redfin大涨67%；医药公司CKPT涨超61%
美国房地产领域两大巨头联手! Rocket豪掷17.5亿美元鲸吞Redfin，后者大涨67%；CKPT涨超61%，获印度制药巨头收购>>
03-11 19:49
3 Penny Stocks to Watch Now, 11/3/25
Sharps Technology, Checkpoint Therapeutics, and Sonoma Pharmaceuticals are the ...
03-11 17:52
美股大行评级 | 杰富瑞：上调爱彼迎评级至"买入"，目标价从165美元升至185美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1106138546093002753.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 瑞杰金融：上调Trevi Therapeutics(TRVI)评级至"强烈买入"，目标价从9美元升至29美元</p> <p>• Needham：维持Trevi Therapeutics(TRVI)"买入"评级，目标价从8美
03-11 10:13
